188 related articles for article (PubMed ID: 27432471)
1. Quantitative proteomics identifies myoferlin as a novel regulator of A Disintegrin and Metalloproteinase 12 in HeLa cells.
Zhou Y; Xiong L; Zhang Y; Yu R; Jiang X; Xu G
J Proteomics; 2016 Oct; 148():94-104. PubMed ID: 27432471
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12.
Xiong L; Yan W; Zubia E; Zhou Y; Zhang Y; Duan Q; Narayan M; Xu G
J Proteomics; 2018 Jun; 182():34-44. PubMed ID: 29729432
[TBL] [Abstract][Full Text] [Related]
3. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
[TBL] [Abstract][Full Text] [Related]
4. Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer.
Fahmy K; Gonzalez A; Arafa M; Peixoto P; Bellahcène A; Turtoi A; Delvenne P; Thiry M; Castronovo V; Peulen O
Int J Cancer; 2016 Feb; 138(3):652-63. PubMed ID: 26311411
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
6. Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.
Blomme A; Fahmy K; Peulen O; Costanza B; Fontaine M; Struman I; Baiwir D; de Pauw E; Thiry M; Bellahcène A; Castronovo V; Turtoi A
Oncotarget; 2016 Dec; 7(50):83669-83683. PubMed ID: 27845903
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Roy R; Dagher A; Butterfield C; Moses MA
Mol Cancer Res; 2017 Nov; 15(11):1608-1622. PubMed ID: 28765266
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
9. Myoferlin is a key regulator of EGFR activity in breast cancer.
Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
[TBL] [Abstract][Full Text] [Related]
10. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
[TBL] [Abstract][Full Text] [Related]
11. SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1.
Duan Q; Li D; Xiong L; Chang Z; Xu G
J Proteome Res; 2019 Jul; 18(7):2903-2914. PubMed ID: 31117637
[TBL] [Abstract][Full Text] [Related]
12. Upregulated expression of ADAM12 is associated with progression of oral squamous cell carcinoma.
Uehara E; Shiiba M; Shinozuka K; Saito K; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Tanzawa H
Int J Oncol; 2012 May; 40(5):1414-22. PubMed ID: 22267082
[TBL] [Abstract][Full Text] [Related]
13. A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis.
Georges S; Chesneau J; Hervouet S; Taurelle J; Gouin F; Redini F; Padrines M; Heymann D; Fortun Y; Verrecchia F
Eur J Cancer; 2013 Jun; 49(9):2253-63. PubMed ID: 23490646
[TBL] [Abstract][Full Text] [Related]
14. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
15. ADAM12-directed ectodomain shedding of E-cadherin potentiates trophoblast fusion.
Aghababaei M; Hogg K; Perdu S; Robinson WP; Beristain AG
Cell Death Differ; 2015 Dec; 22(12):1970-84. PubMed ID: 25909890
[TBL] [Abstract][Full Text] [Related]
16. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion.
Li R; Ackerman WE; Mihai C; Volakis LI; Ghadiali S; Kniss DA
PLoS One; 2012; 7(6):e39766. PubMed ID: 22761893
[TBL] [Abstract][Full Text] [Related]
17. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
Aghababaei M; Perdu S; Irvine K; Beristain AG
Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
19. Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.
Zhu W; Zhou B; Zhao C; Ba Z; Xu H; Yan X; Liu W; Zhu B; Wang L; Ren C
J Cell Mol Med; 2019 Nov; 23(11):7180-7189. PubMed ID: 31475450
[TBL] [Abstract][Full Text] [Related]
20. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
